We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
-1.92%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$218M
AUM Growth
-$20.8M
Cap. Flow
-$5.97M
Cap. Flow %
-2.74%
Top 10 Hldgs %
57.55%
Holding
77
New
10
Increased
15
Reduced
41
Closed
7

Top Buys

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$4.44M
2
PTX
Pernix Therapeutics Holdings, Inc.
PTX
+$3.89M
3
PODD icon
Insulet
PODD
+$2.18M
4
ENZ
Enzo Biochem, Inc.
ENZ
+$2.04M
5
STAA icon
STAAR Surgical
STAA
+$1.78M

Top Sells

Rank Stock Value
1
VIAV icon
Viavi Solutions
VIAV
+$3.18M
2
ALU
Alcatel-Lucent
ALU
+$3.16M
3
SPNC
Spectranetics Corp
SPNC
+$2.92M
4
OMCL icon
Omnicell
OMCL
+$2.57M
5
AKRX
Akorn Inc
AKRX
+$1.8M

Sector Composition

Rank Sector Weight
1 Technology 39.63%
2 Healthcare 32.63%
3 Miscellaneous 14.82%
4 Consumer Staples 5.31%
5 Financials 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTCT
26
DELISTED
CONSTANT CONTACT, INC COM
CTCT
$1.95M 0.9%
60,701
-6,215
-9% -$173K
TLGT
27
DELISTED
Teligent, Inc
TLGT
$1.75M 0.81%
33,019
+31,030
+1,560% +$1.59M
TQNT
28
DELISTED
TRIQUINT SEMICONDUCTOR INC
TQNT
$1.72M 0.79%
108,452
-74,810
-41% -$1.11M
TEAR
29
DELISTED
TearLab Corporation
TEAR
$1.71M 0.78%
35,077
-3,209
-8% -$157K
NEO icon
30
NeoGenomics
NEO
$2.39B
$1.69M 0.78%
508,917
+173,540
+52% +$577K
LAB icon
31
Standard BioTools
LAB
$256M
$1.6M 0.74%
54,451
+5,403
+11% +$173K
IL
32
DELISTED
IntraLinks Holdings Inc.
IL
$1.57M 0.72%
176,895
-10,740
-6% -$96.1K
STRM
33
DELISTED
Streamline Health Solutions
STRM
$1.57M 0.72%
21,780
-2,440
-10% -$181K
EOG icon
34
EOG Resources
EOG
$75.8B
$1.31M 0.6%
11,220
-520
-4% -$54.7K
MAR icon
35
Marriott International
MAR
$92.3B
$1.24M 0.57%
19,343
-769
-4% -$45.6K
LGND icon
36
Ligand Pharmaceuticals
LGND
$5.67B
$1.17M 0.54%
30,212
+22,178
+276% +$900K
WFC icon
37
Wells Fargo
WFC
$257B
$1.17M 0.54%
22,248
-595
-3% -$29.9K
LUV icon
38
Southwest Airlines
LUV
$19.5B
$1.16M 0.53%
43,066
-1,940
-4% -$48.9K
AXP icon
39
American Express
AXP
$226B
$1.13M 0.52%
11,897
-410
-3% -$37K
VOLC
40
DELISTED
VOLCANO CORPORATION COM STK
VOLC
$1.12M 0.51%
63,352
-58,825
-48% -$1.07M
MMM icon
41
3M
MMM
$92.2B
$1.11M 0.51%
9,295
-394
-4% -$46.2K
VFC icon
42
VF Corp
VFC
$5.36B
$1.1M 0.51%
18,543
-679
-4% -$39.5K
PEP icon
43
PepsiCo
PEP
$191B
$1.02M 0.47%
11,403
-208
-2% -$18K
JNJ icon
44
Johnson & Johnson
JNJ
$640B
$998K 0.46%
9,539
-159
-2% -$16.1K
AZO icon
45
AutoZone
AZO
$47.9B
$995K 0.46%
1,855
-35
-2% -$18.5K
DE icon
46
Deere & Co
DE
$168B
$971K 0.45%
10,718
-192
-2% -$17.7K
EMN icon
47
Eastman Chemical
EMN
$8.31B
$947K 0.44%
10,841
-359
-3% -$31.2K
SO icon
48
Southern Company
SO
$102B
$941K 0.43%
20,726
-131
-0.6% -$5.79K
PG icon
49
Procter & Gamble
PG
$333B
$922K 0.42%
11,729
-197
-2% -$15.9K
VZ icon
50
Verizon
VZ
$205B
$913K 0.42%
18,661
-140
-0.7% -$6.78K
1
2
3 4

Similar funds

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return

Kopp Investment Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Kopp Investment Advisors held 77 positions worth $218M, down 8.7% from $238M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Kopp Investment Advisors's Q2 2014 filing shows 10 new, 15 increased, 41 reduced and 7 closed positions. Its largest new stake was Pernix Therapeutics Holdings, Inc.: 63,475 shares worth $5.7M. The largest sale was Viavi Solutions, an estimated $3.18M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, down from 47% a quarter earlier, followed by Healthcare and Miscellaneous.

  • Kopp Investment Advisors's largest Q2 2014 buy was Pernix Therapeutics Holdings, Inc.: 63,475 shares worth $5.7M.
  • Kopp Investment Advisors added most to Supernus Pharmaceuticals in Q2 2014, an estimated $4.44M increase.
  • Kopp Investment Advisors's biggest Q2 2014 reduction was Alcatel-Lucent, cutting an estimated $3.16M.
  • Kopp Investment Advisors fully exited Viavi Solutions in Q2 2014, selling an estimated $3.18M.
  • Kopp Investment Advisors's ten largest holdings make up 58% of its $218M portfolio in Q2 2014.
  • Kopp Investment Advisors opened 10 new positions and closed 7 in Q2 2014.
  • Kopp Investment Advisors's portfolio value fell 8.7% quarter-over-quarter to $218M.

Based on Kopp Investment Advisors's 13F filing for Q2 2014, filed 1 Aug 2014.